✦ LIBER ✦

Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells

✍ Scribed by Topaly, J; Zeller, W J; Fruehauf, S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of a selective Abl tyrosine kinas

✍ Kawaguchi, Y; Jinnai, I; Nagai, K; Yagasaki, F; Yakata, Y; Matsuo, T; Kuriyama, 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 546 KB

ABL-specific tyrosine kinase inhibitor,

✍ Nakajima, A; Tauchi, T; Ohyashiki, K 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 121 KB

The in vitro activity of the tyrosine ki

✍ Liu, W M; Stimson, L A; Joel, S P 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 143 KB

Favorable therapeutic index of a p210BCR

✍ Bernd Kasper; Stefan Fruehauf; Bernd Schiedlmeier; Elisabeth Buchdunger; Anthony 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 170 KB